Medicalgorithmics Signs New Contract with USA based Independent Diagnostic Testing Facility
Medicalgorithmics, a medtech company listed on the Warsaw Stock Exchange, Poland, included in the sWIG80 index, a provider of technological solutions for cardiology, has signed an agreement with another U.S.-based Independent Diagnostic Testing Facility (IDTF). The agreement includes the utilization of the company’s AI software, algorithms, and platform. Once integrated, this will allow for the analysis of ECG data, connecting the American partner’s devices with Medicalgorithmics’ advanced software for heart disease diagnostics. This marks the second contract Medicalgorithmics has entered into with a U.S. IDTF since announcing their new strategy in June.